Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? von Santini, D., Vincenzi, B., Addeo, R., Garufi, C., Masi, G., Scartozzi, M., Mancuso, A., Frezza, A.M., Venditti, O., Imperatori, M., Schiavon, G., Bronte, G., Cicero, G., Recine, F., Maiello, E., Cascinu, S., Russo, A., Falcone, A., Tonini, G.

Volltext

PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors von Garufi, C., Mancuso, S., Ceccarelli, F., Caruso, L., Alessandri, C., Di Franco, M., Priori, R., Riccieri, V., Scrivo, R., Truglia, S., Conti, F., Spinelli, F.R.

Volltext

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial von Garufi, C, Torsello, A, Tumolo, S, Ettorre, G M, Zeuli, M, Campanella, C, Vennarecci, G, Mottolese, M, Sperduti, I, Cognetti, F

Volltext

Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis von Giacchetti, S., Dugué, P.A., Innominato, P.F., Bjarnason, G.A., Focan, C., Garufi, C., Tumolo, S., Coudert, B., Iacobelli, S., Smaaland, R., Tampellini, M., Adam, R., Moreau, T., Lévi, F.

Volltext

Complementemia in pregnancies with antiphospholipid syndrome von Tabacco, S, Giannini, A, Garufi, C, Botta, A, Salvi, S, Del Sordo, G, Benedetti Panici, P, Lanzone, A, De Carolis, S

Volltext

Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort von Spinelli, F R, Moscarelli, E, Ceccarelli, F, Miranda, F, Perricone, C, Truglia, S, Garufi, C, Massaro, L, Morello, F, Alessandri, C, Valesini, G, Conti, F

Volltext

Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR... von Pinto, C., Di Fabio, F., Maiello, E., Pini, S., Latiano, T., Aschele, C., Garufi, C., Bochicchio, A., Rosati, G., Aprile, G., Giaquinta, S., Torri, V., Bardelli, A., Gion, M., Martoni, A.

Volltext

Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment? von De Carolis, S, Botta, A, Salvi, S, di Pasquo, E, Del Sordo, G, Garufi, C, Lanzone, A, De Carolis, M.P

Volltext

Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women von De Carolis, S, Tabacco, S, Rizzo, F, Perrone, G, Garufi, C, Botta, A, Salvi, S, Benedetti Panici, P, Lanzone, A

Volltext

Lupus anticoagulant remission after gluten-free diet in a coeliac pregnant woman von Tabacco, S, Garufi, C, Giannini, A, Lanzone, A, Benedetti Panici, P, Rizzo, F, Salvi, S, De Carolis, S

Volltext

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? von Santini, D, Vincenzi, B, Addeo, R, Garufi, C, Masi, G, Scartozzi, M, Mancuso, A, Frezza, A M, Venditti, O, Imperatori, M, Schiavon, G, Bronte, G, Cicero, G, Recine, F, Maiello, E, Cascinu, S, Russo, A, Falcone, A, Tonini, G

Volltext

Corrections to “Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?” von Santini, D., Vincenzi, B., Addeo, R., Garufi, C., Masi, G., Scartozzi, M., Mancuso, A., Frezza, A.M., Venditti, O., Imperatori, M., Schiavon, G., Bronte, G., Cicero, G., Recine, F., Maiello, E., Cascinu, S., Russo, A., Falcone, A., Tonini, G.

Volltext

Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? von De Carolis, M P, Salvi, S, Botta, A, Cocca, C, Garufi, C, Lanzone, A, De Carolis, S

Volltext

2196 Polymorphisms and miRNAs targeting CLOCK gene affect gender-related survival in metastatic colorectal cancer (mCRC) patients (pts) von Torsello, A, Ruzzo, A, Sperduti, I, Melucci, E, Giacomini, E, Mottolese, M, Fiorino, R, Zeuli, M, Pescarmona, E, Magnani, M, Cognetti, F, Garufi, C

Volltext

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients von Cortellini, Alessio, Chiari, Rita, Ricciuti, Biagio, Metro, Giulio, Perrone, Fabiana, Tiseo, Marcello, Bersanelli, Melissa, Bordi, Paola, Santini, Daniele, Giusti, Raffaele, Grassadonia, Antonino, Di Marino, Pietro, Tinari, Nicola, De Tursi, Michele, Zoratto, Federica, Veltri, Enzo, Malorgio, Francesco, Garufi, Carlo, Russano, Marco, Anesi, Cecilia, Zeppola, Tea, Filetti, Marco, Marchetti, Paolo, Berardi, Rossana, Rinaldi, Silvia, Tudini, Marianna, Silva, Rosa Rita, Pireddu, Annagrazia, Atzori, Francesco, Iacono, Daniela, Migliorino, Maria Rita, Porzio, Giampiero, Cannita, Katia, Ficorella, Corrado, Buti, Sebastiano

Volltext

The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome von De Carolis, S, Santucci, S, Botta, A, Salvi, S, Degennaro, VA, Garufi, C, Garofalo, S, Ferrazzani, S, Scambia, G

Volltext

P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: Distribution and prognostic relevance von Torsello, A, Garufi, C, Cosimelli, M, Diodoro, M.G, Zeuli, M, Vanni, B, Campanella, C, D’Angelo, C, Sperduti, I, Donnorso, R. Perrone, Cognetti, F, Terzoli, E, Mottolese, M

Volltext

521P Deciphering a three-miRNA signature as a prognostic biomarker in glioma patients: Correlation with DFS and OS von Mendez, A.B. Diaz, Di Giuliani, M., Sacconi, A., Regazzo, G., Ramponi, S., Blandino, G., Garufi, C., Rizzo, M.G.

Volltext

1613P The BreakThrough cancer malnutrition von De Santis, S., Nazzicone, G., Petricola, F., Bacciu, O., Scarcella, F., Amadei, A., Tonini, G., Roselli, M., Garufi, C.

Volltext

T.03.3: THE ROLE OF PHOSPHORUS-32 IN THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER von Sbrozzi Vanni, A., Mattana, M., Meddi, P., Chiacchiararelli, L., Iacono, D., Barucca, V., Ventroni, G., Garufi, C., Faggiani, R.

Volltext